AZTA · Azenta Inc
United States · RS rating 75 · As of 2026-11-03
| Price | 37.14 USD |
|---|---|
| 1-day change | +4.5% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 30 / 88 / 70 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 42 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -133.3% |
| Sales growth Q/Q | -6.5% |
| Distance from 52-week high | +13.1% |
| Market cap (USD) | $1.2B |